关于撤消“凋亡蛋白Bax在肿瘤坏死因子凋亡诱导配体诱导恶性淋巴瘤细胞耐药中的调节作用”论文的声明  

Announcement of Retraction about the Article"The Modulating Effect of Proapoptotic Protein Bax on the Resistance of Malignant Lymphoma Cells to Tumor Necrosis Factor Related Apoptosis Inducing Ligand-Induced Apoptosis"

作　　者：National Medical Journal of China 

机构地区：[1]中华医学杂志编辑部

出　　处：《中华医学杂志》2007年第36期2570-2570,共1页National Medical Journal of China

摘　　要：我们遗憾地声明，撤消刊登在《中华医学杂志》2007，87：134-137页上署名郝继辉等的文章（HAO ji-hui eta1．Themodulating effect of proapoptotic protein Bax on the resistance of malignant lymphoma cells to tumor necrosis factor related apoptosis inducing ligand-induced apoptosis）。We regretfully retract the following article：＂ HAO Ji-hui et al, The modulating effect of proapoptotic protein Bax on the resistance of malignant lymphoma cells to tumor necrosis factor related apoptosis inducing ligand-induced apoptosis＂, published in National Medical Journal of China 2007,87 ： 134-137. We are taking this action at the request of the author. The author wrote letter to our Editorial Office to clarified： the work of the paper was finished in Queen Mary University and he took part in it. The intellectual property of this work entirely belongs to theInstitute of Cell and Molecular Science, Queen Mary University of London. Without the permission of British University and Jia Li, Liu Feng-ting, he published the paper. The author beg to withdraw the paper from the journal, and apologize to readers and editors. The National Medical Journal of China apologize for inconveniencing you in this way.

关 键 词：肿瘤坏死因子凋亡诱导配体 蛋白BAX 恶性淋巴瘤 细胞耐药 调节作 apoptosis 《中华医学杂志》 LYMPHOMA 

分 类 号：R733.1[医药卫生—肿瘤]